Active Ingredient
(in each tablet)
Dimenhydrinate 50 mg
The following Structured Product Label (SPL) was submitted to the FDA by Medtech Products Inc. for the product Dramamine Original Formula (NDC 63029-901). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, use, do not give to, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each tablet)
Dimenhydrinate 50 mg
Antiemetic
for prevention and treatment of these symptoms associated with motion sickness:
children under 2 years of age unless directed by a doctor.
taking sedatives or tranquilizers.
ask a doctor before use.
In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.
| Adults and children 12 years and over |
|
| Children 6 to under 12 years |
|
| Children 2 to under 6 years |
|
colloidal silicon dioxide, croscarmellose sodium, lactose, magnesium stearate, microcrystalline cellulose
Call 1-800-382-7219
Dramamine.com
Dramamine®
motion sickness
Original
Dimenhydrinate tablets/antiemetic
12 tablets (50 mg each)
Dramamine®
motion sickness
Original
Dimenhydrinate tablets/antiemetic
36 tablets (50 mg each)
* Please review the disclaimer below.